Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alterity Therapeutics ( (AU:ATH) ) has shared an announcement.
Alterity Therapeutics Limited announced the quotation of 1,666,666,663 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of September 15, 2025. This move is part of a previously announced transaction, potentially enhancing the company’s financial flexibility and market presence, which could have implications for its strategic initiatives and stakeholder interests.
More about Alterity Therapeutics
Alterity Therapeutics Limited operates in the biotechnology industry, focusing on developing therapies for neurodegenerative diseases. The company primarily works on treatments that target conditions like Alzheimer’s and Parkinson’s disease, aiming to address significant unmet medical needs in these areas.
YTD Price Performance: 20.0%
Average Trading Volume: 13,499,487
Technical Sentiment Signal: Sell
Current Market Cap: A$115.1M
Find detailed analytics on ATH stock on TipRanks’ Stock Analysis page.